Protein

Newly discovered signal could lead to anti-cancer therapies

31 July 2019 | By Drug Target Review

Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.

New discovery could lead to new treatments for Parkinson’s

30 July 2019 | By Drug Target Review

New discovery makes it possible to design new therapies to replace alpha-synuclein's function in people with Parkinson's disease.

Enzo Life Sciences

Scientists control living cells using artificial protein switch

24 July 2019 | By Drug Target Review

Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.

Promising drug developed for ovarian and pancreatic cancers

22 July 2019 | By Drug Target Review

An antibody has been developed to block a protein secreted by the cells surrounding ovarian and pancreatic cancer tumours.

Transfer of oncogene in colon cancer cells demonstrated

22 July 2019 | By Drug Target Review

A new study has shown that proteins derived from the oncogene, KRAS, can transfer between colon cancer cells.

Whitepaper: Neural Cell Culturing Guide

22 July 2019 | By Bio-Techne

The advent of in vitro culturing of neural cells has been central to driving our understanding of the nervous system.

Whitepaper: Immune Cell Isolation & Culture

22 July 2019 | By Bio-Techne

Immune cell isolation and culture are necessary for both basic research aimed at investigating the functions of different immune cell types, and for expanding specific immune cell populations for therapeutic purposes.

Leukemia stem cells made visible to the immune system

19 July 2019 | By Drug Target Review

A new study may provide the basis for combating malignant leukemia stem cells.

Study shows p38 protein regulates formation of new blood vessels

18 July 2019 | By Drug Target Review

A new study shows that the activity of p38 is important in MSCs, which can localise around blood vessels.

New potential liver cancer treatment found with biomarker-guided strategy

16 July 2019 | By European Pharmaceutical Review

A cellular pathway may reduce side effects and extend immunotherapy duration in patients with the most common form of liver cancer.

Role of protein in spread of cytomegalovirus discovered

11 July 2019 | By Victoria Rees (Drug Target Review)

A study has revealed the role of a protein which enables human cytomegalovirus to spread, the number one cause of congenital birth defects in the world.

Inhibiting protein slows glioblastoma tumour growth

11 July 2019 | By Victoria Rees (Drug Target Review)

Researchers have discovered that inhibiting the ID1 protein slows the growth of glioblastoma tumours and reduces resistance to chemotherapy.

‘Longevity gene’ could be replicated to fight cardiovascular disease

10 July 2019 | By Drug Target Review

The so-called 'longevity gene' has been included in animal models, in which it stopped atherosclerosis.

Discovering new routes to cancer drug discovery with neutrons

8 July 2019 | By Matthew Blakeley

From the world’s flagship neutron science facility, Institut Laue-Langevin (ILL), Matthew Blakeley shares insights into how they are harnessing the power of neutrons to aid their search for new cancer treatments.